Cancer Immunology and Immunotherapy

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Cancer Immunology and Immunotherapy by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg Publication: April 11, 2011
Imprint: Springer Language: English
Author:
ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg
Publication: April 11, 2011
Imprint: Springer
Language: English

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

More books from Springer Berlin Heidelberg

Cover of the book Digitale Signalverarbeitung in der Messtechnik by
Cover of the book Polar Auxin Transport by
Cover of the book Responsible Communication by
Cover of the book Hidden Hunger by
Cover of the book Biopolymers from Renewable Resources by
Cover of the book Chemical and Physical Behavior of Human Hair by
Cover of the book Echinoderm Research and Diversity in Latin America by
Cover of the book Verteiltes und Paralleles Datenmanagement by
Cover of the book Marketing: Grundlagen by
Cover of the book Kurzschaftendoprothesen an der Hüfte by
Cover of the book Silver Nanoparticles in the Environment by
Cover of the book Honeybees of Asia by
Cover of the book Aktien richtig bewerten by
Cover of the book Environmental Epigenomics in Health and Disease by
Cover of the book The Practice of Radiology Education by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy